NEOPHORE LIMITED

10762171
Active Altrincham

Research and experimental development on biotechnology

10 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
N

NEOPHORE LIMITED

10762171

Research and experimental development on biotechnology

Founded 9 May 2017 Active Altrincham, United Kingdom 10 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 1 Jun 2026 Next due 31 Dec 2026 6 months remaining
Confirmation Submitted 15 May 2026 Next due 22 May 2027 11 months remaining
Net assets £9M £2M 2024 year on year
Total assets £11M £2M 2024 year on year
Total Liabilities £1M £359K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

3rd Floor 1 Ashley Road Altrincham Cheshire WA14 2DT United Kingdom

Telephone

0800 000 0000

Website

www.example.com

Full company profile for NEOPHORE LIMITED (10762171), an active life sciences and medical technology company based in Altrincham, United Kingdom. Incorporated 9 May 2017. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Apr → 31 Mar 2025
Type small
Next accounts 31 Mar 2026
Due by 31 Dec 2026 6 months remaining

Net Assets, Total Assets & Total Liabilities (2017–2024)

Cash in Bank

£9.11M

Decreased by £1.99M (-18%)

Net Assets

£9.14M

Decreased by £2.00M (-18%)

Total Liabilities

£1.47M

Decreased by £359.15k (-20%)

Turnover

N/A

Employees

10

Debt Ratio

14%

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Mar Year End
2024
31 Mar Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 6
Grants 1

Investors (12)

Investor NameInvestor SinceParticipating Rounds
Investor 1Nov 2017Series B, Series A
Investor 6Nov 2017Seed
Investor 2Mar 2021Series B

Share Capital

Share Capital

Share allotments and capital structure

16 Allotments 2,612,649 Shares £40.22m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
21 Jun 202416,291£16.291£0.001
3 Apr 2024294,516£5.02m£17.05
5 Jan 2024563,591£9.61m£17.05
8 Dec 2022337,243£5.75m£17.05
31 Jan 2022576,062£9.36m£16.24

Officers

Officers

2 active 1 resigned
Status
Bjordal, Marianne, DrDirectorNorwegianFrance496 Mar 2024Active
Oakwood Corporate Secretary LimitedCorporate-secretaryUnited KingdomUnknown9 May 2017Active

Shareholders

Shareholders (87)

Crt Pioneer Gp Limited (as Nominee For Crt Pioneer Fund Lp)
13.1%
369,560
Bristol-myers Squibb Company
10.4%
293,255

Persons with Significant Control

Persons with Significant Control (0)

0 Active 3 Ceased

Christopher John Torrance

Ceased 8 Nov 2017

Ceased

Jeffrey James Roix

Ceased 8 Nov 2017

Ceased

Crt Pioneer Gp Limited

Ceased 5 Jan 2024

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
1 Jun 2026AccountsAnnual accounts made up to 31 Mar 2026
15 May 2026OfficersChange to director Pietro Puglisi on 9 Dec 2024
15 May 2026Confirmation StatementConfirmation statement made on 8 May 2026 with updates
10 Oct 2025OfficersChange to director Dr Marianne Bjordal on 1 Oct 2025
7 Jul 2025AccountsAnnual accounts made up to 31 Mar 2025
1 Jun 2026 Accounts

Annual accounts made up to 31 Mar 2026

15 May 2026 Officers

Change to director Pietro Puglisi on 9 Dec 2024

15 May 2026 Confirmation Statement

Confirmation statement made on 8 May 2026 with updates

10 Oct 2025 Officers

Change to director Dr Marianne Bjordal on 1 Oct 2025

7 Jul 2025 Accounts

Annual accounts made up to 31 Mar 2025

Recent Activity

Latest Activity

Annual accounts made up to 31 Mar 2026

2 weeks ago on 1 Jun 2026

Change to director Pietro Puglisi on 9 Dec 2024

1 months ago on 15 May 2026

Confirmation statement made on 8 May 2026 with updates

1 months ago on 15 May 2026

Change to director Dr Marianne Bjordal on 1 Oct 2025

8 months ago on 10 Oct 2025

Annual accounts made up to 31 Mar 2025

11 months ago on 7 Jul 2025